|本期目录/Table of Contents|

[1]张一丹综述,张兴虎审校.老年人肌少症风险因素评估及管理研究进展[J].医学研究与战创伤救治(原医学研究生学报),2017,19(05):508-512.[doi:10.3969/j.issn.1672-271X.2017.05.015]
点击复制

老年人肌少症风险因素评估及管理研究进展()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第19卷
期数:
2017年05期
页码:
508-512
栏目:
综述
出版日期:
2017-09-29

文章信息/Info

Title:
-
作者:
张一丹综述; 张兴虎审校
作者单位：210002 南京，南京军区南京总医院干部病房一科
Author(s):
-
关键词:
肌少症; 风险因素; 综合评估; 管理
Keywords:
-
分类号:
R685
DOI:
10.3969/j.issn.1672-271X.2017.05.015
文献标志码:
A
摘要:
肌少症是目前临床上一种潜在、频发的老年综合症，具有老龄化所引起的骨骼肌肌肉减少和肌肉力量下降并伴随身体功能减退的临床特点，是导致老年人日常生活活动受限、摔倒、残障、死亡风险增加的重要因素。目前，临床工作者越来越关注老年肌少症的发病风险和相关的防治干预手段，以期减少并发症，提高老年患者的生活质量。文章对老年肌少症的风险因素、诊治以及干预手段等方面进行综述。
Abstract:
-

参考文献/References:

[1]Wang H, Hai S, Cao L, et al. Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people [J]. BMC Geriatr,2016, 16(1): 216.
[2］Dutta C. Significance of sarcopenia in the elderly [J]. J Nutr,1997, 127(5 Suppl): 992s-993s.
[3］Rosenberg IH. Sarcopenia: origins and clinical relevance [J]. J Nutr,1997, 127(5 Suppl): 990s-991s.
[4］Marcell TJ. Sarcopenia: causes, consequences, and preventions [J]. J Gerontol A Biol Sci Med Sci,2003, 58(10): M911-916.
[5］Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study [J]. J Gerontol A Biol Sci Med Sci,2006, 61(10): 1059-1064.
[6］Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People [J]. Age Ageing,2010, 39(4): 412-423.
[7］Faulkner JA, Larkin LM, Claflin DR, et al. Age-related changes in the structure and function of skeletal muscles [J]. Clin Exp Pharmacol Physiol,2007, 34(11): 1091-1096.
[8］Drummond MJ, Dreyer HC, Pennings B, et al. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging [J]. J Appl Physiol(1985),2008, 104(5): 1452-1461.
[9］Hai S, Cao L, Wang H, et al. Association between sarcopenia and nutritional status and physical activity among community-dwelling Chinese adults aged 60 years and older [J]. Geriatr Gerontol Int,2017. [Epub ahead of print]
[10］Grune T, Shringarpure R, Sitte N, et al. Age-related changes in protein oxidation and proteolysis in mammalian cells [J]. J Gerontol A Biol Sci Med Sci,2001, 56(11): B459-467.
[11］Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia [J]. Curr Opin Clin Nutr Metab Care,2012, 15(1): 12-22.
[12］Petersen AM, Pedersen BK. The role of IL-6 in mediating the anti-inflammatory effects of exercise [J]. J Physiol Pharmacol,2006, 57(Suppl 10): 43-51.
[13］Edstrom E, Altun M, Bergman E, et al. Factors contributing to neuromuscular impairment and sarcopenia during aging [J]. Physiol Behav,2007, 92(1-2): 129-135.
[14］Sayer AA, Syddall HE, Gilbody HJ, et al. Does sarcopenia originate in early life? Findings from the Hertfordshire cohort study [J]. J Gerontol A Biol Sci Med Sci,2004, 59(9): M930-934.
[15］Sourdet S, Rougé-Bugat ME, Vellas B, et al. Frailty and aging [J]. J Nutr Health Aging,2012, 16(4): 283-284.
[16］Clegg A, Young J, Iliffe S, et al. Frailty in elderly people(vol 381, pg 752, 2013) [J]. Lancet,2013, 382(9901): 1328-1328.
[17］Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition [J]. Clin Nutr,2008, 27(6): 793-799.
[18］Durham WJ, Dillon EL, Sheffield-Moore M. Inflammatory burden and amino acid metabolism in cancer cachexia [J]. Curr Opin Clin Nutr Metab Care,2009, 12(1): 72-77.
[19］Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups(SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”[J]. Clin Nutr,2010, 29(2): 154-159.
[20］Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity: definition, cause and consequences [J]. Curr Opin Clin Nutr Metab Care,2008, 11(6): 693-700.
[21］Batsis JA, Mackenzie TA, Lopez-Jimenez F, et al. Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004 [J]. Nutr Res,2015, 35(12): 1031-1039.
[22］Song MY, Ruts E, Kim J, et al. Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women [J]. Am J Clin Nutr,2004, 79(5): 874-880.
[23］Curcio F, Ferro G, Basile C, et al. Biomarkers in sarcopenia: A multifactorial approach [J]. Exp Gerontol,2016, 85: 1-8.
[24］De Rui M, Veronese N, Bolzetta F, et al. Validation of bioelectrical impedance analysis for estimating limb lean mass in free-living Caucasian elderly people [J]. Clin Nutr,2017, 36(2): 577-584.
[25］Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia [J]. J Am Med Dir Assoc,2014, 15(2): 95-101.
[26］Chen LK, Lee WJ, Peng LN, et al. Recent Advances in Sarcopenia Research in Asia: 2016 Update From the Asian Working Group for Sarcopenia [J]. J Am Med Dir Assoc,2016, 17(8): 767.e761-767.
[27］Zanandrea V, Giua R, Costanzo L, et al. Interventions against sarcopenia in older persons [J]. Curr Pharm Des,2014, 20(38): 5983-6006.
[28］Marini M, Sarchielli E, Brogi L, et al. Role of adapted physical activity to prevent the adverse effects of the sarcopenia. A pilot study [J]. Ital J Anat Embryol,2008, 113(4): 217-225.
[29］Liu C, Latham NK. Progressive resistance strength training for improving physical function in older adults [J]. Int J Older People Nurs,2009, 6(3): CD002759.
[30］Burd NA, Gorissen SH, van Loon LJ. Anabolic resistance of muscle protein synthesis with aging [J]. Exerc Sport Sci Rev,2013, 41(3): 169-173.
[31］Phillips SM, Chevalier S, Leidy HJ. Protein “requirements” beyond the RDA: implications for optimizing health [J]. Appl Physiol Nutr Metab,2016, 41(5): 565-572.
[32］Bartoszewska M, Kamboj M, Patel DR. Vitamin D, muscle function, and exercise performance [J]. Pediatr Clin North Am,2010, 57(3): 849-861.
[33］Bosaeus I, Rothenberg E. Nutrition and physical activity for the prevention and treatment of age-related sarcopenia [J]. Proc Nutr Soc,2016, 75(2): 174-180.
[34］West DW, Phillips SM. Anabolic processes in human skeletal muscle: restoring the identities of growth hormone and testosterone [J]. Phys Sportsmed,2010, 38(3): 97-104.
[35］Sumukadas D, Witham MD, Struthers AD, et al. Ace inhibitors as a therapy for sarcopenia-evidence and possible mechanisms [J]. J Nutr Health Aging,2008, 12(7): 480-485.
[36］Ashfield TA, Syddall HE, Martin HJ, et al. Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study [J]. Age Ageing,2010, 39(2): 185-191.
[37］潘卫民. 医院老年科药师应重视开展老年人用药健康教育[J]. 东南国防医药, 2004, 6(3):180-181.

相似文献/References:

[1]曹丽霞,李晶晶,董 娟,等.危重症患者行床旁连续性血液净化治疗的护理风险管理探讨[J].医学研究与战创伤救治(原医学研究生学报),2015,17(01):87.[doi:10.3969/j.issn.1672-271X.2015.01.030]
[2]范志刚,夏巍巍,潘森鑫,等.某部新兵跖骨行军骨折风险因素的多元logistic回归分析[J].医学研究与战创伤救治(原医学研究生学报),2017,19(05):484.[doi:10.3969/j.issn.1672-271X.2017.05.009]
　FAN Zhi-gang,XIA Wei-wei,PAN Sen-xin,et al.Multivariate logistic regression analysis of risk factors for fracture of metatarsal bones in recruits[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(05):484.[doi:10.3969/j.issn.1672-271X.2017.05.009]
[3]戴卉,张暐,缪小红,等.中性粒细胞/淋巴细胞比值联合营养风险筛查对老年肌少症患者的诊断价值[J].医学研究与战创伤救治(原医学研究生学报),2023,25(3):242.[doi:10.3969/j.issn.1672-271X.2023.03.004]
　DAI Hui,ZHANG Wei,MIAO Xiaohong,et al.The diagnostic value of neutrophil/lymphocyte ratio combined with nutritional risk screening in senile patients with sarcopenia[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2023,25(05):242.[doi:10.3969/j.issn.1672-271X.2023.03.004]
[4]杨琳,任梦婷,马晓青综述,等.运动疗法防治老年肌少症的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2023,25(3):296.[doi:10.3969/j.issn.1672-271X.2023.03.015]
　YANG Lin,REN Mengting,MA Xiaoqing,et al.Research progress of exercise therapy against sarcopenia in elderly patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2023,25(05):296.[doi:10.3969/j.issn.1672-271X.2023.03.015]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2017-09-20